Press Releases

Friday, November 28th, 2008

Cardiome Discloses Chairman and CEO’s Involuntary Share Sale


Friday, November 14th, 2008

Cardiome Reports Third Quarter Results


Thursday, October 23rd, 2008

Cardiome Announces Filing of Shelf Registration Statement


Thursday, October 9th, 2008

Cardiome Provides Regulatory Update


Tuesday, August 12th, 2008

Cardiome Reports Second Quarter Results


Monday, August 11th, 2008

Cardiome to Release Second Quarter Results and Hold Conference Call


Monday, August 11th, 2008

Cardiome and Astellas Announce Receipt of FDA Approvable Letter for KYNAPID


Wednesday, July 23rd, 2008

Cardiome Announces Preferred Share Financing


Monday, July 14th, 2008

Cardiome Announces Positive Phase 2b Results for Oral Vernakalant


Sunday, July 13th, 2008

Cardiome to Hold Conference Call